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ABSTRACT
Objective: This study aimed to identify the relationship between knowledge and beliefs about drugs with adherence of drug use based on the health 
belief model (HBM) theory.
Methods: Respondents were elderly hypertensive patients who received their medicine by prescription in one pharmacy in Surabaya. Knowledge and 
belief variables were measured by a validated questionnaire, while medication adherence was measured by pill count.
Results: There were 57 respondents aged 60-88 years, 54.4% of which are female. A total of 57.9% of respondents used at least two kinds of anti-
hypertension drugs and 54.4% had health problems other than hypertension. The results of Pearson analysis show that respondents’ knowledge about 
the drug had a significant relationship with perceived threat, perceived benefit (p=0.043), and perceived self-efficacy (p=0.015), but no significant 
relationship with adherence, while the result of Spearman analysis shows that only perceived barrier had a significant relationship to adherence 
(p=0.029).
Conclusion: To conclude, efforts to improve adherence was to lower perceived barrier which was primarily associated with decreased physical ability 
and concerns about the dangers of long-term drug use.
Keywords: Adherence, Health belief model, Elderly people, Hypertension.
INTRODUCTION
The improvement of living standards and prosperity has an impact 
on the increasing life expectancy of the Indonesian people, resulting 
in a change in the proportion of the elderly population. In 2010, the 
elderly population was recorded at 7.56% of the entire population 
and is expected to increase to 11.83% in 2025 and 15.77% in 2035, 
respectively [1]. The increasing impacts on the shift of health problems 
include the increased incidence of chronic and degenerative diseases, 
according to the results of the Basic Health Research 2013 [2].
The rising trend of pathological conditions among the elderly led 
to an increase in drug use, as shown in a study in Surabaya in 2012 
involving 382 elderly respondents were 65.44% of respondents use 
at least two kinds of drugs, and 23.56% of respondents use five or 
more different drugs [3]. The use of various types of drugs with the 
different regimentation of the elderly can increase the risk of drug-
related problems including adverse reactions, drug interactions, toxic 
reactions, and nonadherence in drug use [4].
Adherence to drug use is one of the important components in achieving 
therapeutic goals. However, the drug therapy that has been defined by 
various pharmacological considerations, designed dosage forms, and 
latest technology formulation will not yield any benefits if the patient is 
not willing or not able to use the drug correctly. However, the incorrect 
use of drugs by a patient cannot merely be seen as the fault of the 
patient. The nonadherence of drug use involves many aspects that come 
from within or outside the will of the patient so that the process of using 
drugs is not merely a pharmacological process, but also a psychological, 
interpersonal, and social process [5].
In the elderly, no adherence can be fatal considering some physiological 
changes that occur as a result of the aging process. Those physiological 
changes impact the pharmacokinetics and pharmacodynamics of drugs, 
including the reduction in the proportion of bodily fluids that can increase 
the concentration of drug in the blood, a decrease in the production of 
several enzymes including metabolic enzymes, and decreased kidney 
function that affects the rate of drug elimination [6]. In these conditions, 
improper use of drugs may increase the risk of drug toxicity.
This study aimed to identify the adherence to antihypertensive 
medication use among the elderly in Surabaya with an approach based 
on the health beliefs model (HBM) theory. The selection of hypertensive 
patients as research subjects was based on the consideration that 
hypertension is a disease with a large number of cases in Indonesia and 
its prevalence increases among the elderly [2]. The asymptomatic nature 
of hypertension causes the adherence tends to be low. Meanwhile, a 
low adherence of drug use in hypertensive patients can accelerate 
the progression of the disease and organ damage that will increase 
morbidity and mortality, which in turn increase health expenses and 
health-care facilities [7,8].
METHODS
Respondents and research procedure
Respondents in this study were elderly patients (aged 60 years or 
older) who obtained their antihypertensive drugs at one pharmacy in 
Surabaya, Indonesia, during the month of March 2015 using Indonesian 
National Health Insurance facilities. All patients who met the criteria 
were given informed consent. The data collection was performed 
at the patients’ houses at the agreed time. There were 107 eligible 
patients; 27 patients were not found at the address recorded in the 
data pharmacies, 20 patients refused to be respondents, and 3 patients 
cannot continue to be the respondent in pill count to 2 due to death (1) 
and moving out of town (2), making the final group of respondents in 
this research were 57 patients.
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i8.19060
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The HBM measures
A questionnaire was prepared based on a construct in the HBM theory 
developed by Rosenstock with modifications [9,10] as shown in Fig. 1.
The variables measured were the patients’ characteristics and 
knowledge about drugs (modifying factors). The belief in the drugs used 
(individual beliefs) includes the perceived threat, perceived benefits, 
perceived barriers, perceived self-efficacy, and the adherence of drug 
use (behaviors). The collection of data on the variables of knowledge 
and belief used a questionnaire that had been validated, while the 
variable of adherence was collected based on the observation list with 
pill count method.
The characteristics of respondents identified in this study were age, sex, 
latest degree of education, duration, and the condition of hypertension 
when first diagnosed, the number of antihypertensive medications used, 
and a number of other health problems. The hypertensive condition 
when first diagnosed was determined based on a classification 
according to JNC7 [11]. The information on the time and conditions of 
hypertension was based on information from the patient.
The variable of knowledge was compiled based on the Decree of the 
Minister of Health on the Standards of Pharmaceutical Services in 
Pharmacies [12]. Information to patients should be given to patients 
related to the drug used by those standards, including the name and 
purpose of use, rules of use, duration of use, undesirable effects and 
the means to resolve them, and how drugs were stored. There were 11 
statements about their knowledge with a score of 1 to a “true” answer 
and 0 for a “false” or “not applicable” answer.
Belief in the drug use was measured using a Likert scale with a score 
of 1-5 in favorable statements and 5-1 to unfavorable statements. 
Perceived threat was defined as the patient’s perception of the threat 
of hypertension when nonadherent in the use of drugs, which were 
translated into 5 statements describing two parameters, namely, 
the occurrence of complications and declining health conditions. 
Perceived benefit was defined as a patient’s perception of the benefits 
of drug therapy and adherence in drug use (5 statements). Perceived 
barriers describe patients’ perceptions of barriers to adhering to the 
use drugs that include the onset of undesirable effects, complex usage, 
and disruption of daily activities (6 statements). Perceived self-efficacy 
describes the patient’s perception of their ability to adhere to the drug 
consisting of the ability to read the instructions, correct usage, and the 
punctuality of the time to take the medication (7 statements) [13].
Medication adherence
A counting of the drug in the patients’ houses was performed 1 or 2 days 
after the last patient visit to the pharmacy to determine the amount 
of the baseline drug. The next visit was performed about 25 days after 
the first visit to determine the remaining amount of the drug. The 
adherence to drug use is calculated based on drugs used by patients 
compared with drugs that are supposed to be used in the period of data 
collection. Patients were declared adherent if the calculation results of 
pill count were ≥70%.
Analysis
The Pearson correlation test was used to see the relationship between 
belief and knowledge and Spearman to see the relationship between 
the knowledge and belief with the adherence of drug use.
RESULTS AND DISCUSSION
Characteristics of respondents
The characteristics of respondents can be shown in Table 1.
As shown in Table 1 the age range of respondents is between 60 and 
88 years with an average age of respondents being 67.28±6.097. 
Female respondents were more than male respondents. In Indonesia, 
the prevalence of hypertension in females tends to be higher than in 
males [2]. The education level of respondents ranged from elementary 
school dropout to college graduate. The total of 33 (57.9%) of 
respondents were diagnosed with hypertension since <10 years ago. 
When first diagnosed, 39 (68.4%) of respondents have had stage 2 
Fig. 1. The conceptual framework of the study
Table 1: Characteristics of respondents
No. Characteristics Criteria n (%)






2 Gender Male 26 (45.6)
Female 31 (54.4)
3 Latest education Did not complete elementary 
school
1 (1.8)
Elementary school/equivalent 7 (12.3)
Junior high school/equivalent 12 (21.1)






Stage 1 hypertension 16 (28.1)
Stage 2 hypertension 39 (68.4)
5 Duration of 
hypertension 
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hypertension with systolic blood pressure of ≥160 mmHg and/or 
diastolic blood pressure of ≥100 mmHg. Hypertension is often called 
the “silent killer” due to its asymptomatic nature. The delay of the 
treatment occurs because people do not realize that their blood pressure 
has exceeded the normal blood pressure, while the common symptoms 
that often appear like headaches often can be treated with analgesics 
that can be obtained by self-medication [14]. A total of 33 (57.9%) of 
respondents used two different antihypertensive drugs, and there were 
7 (12.4%) of respondents using 3-5 kinds of antihypertensive drugs. 
The treatment with one antihypertensive drug is highly recommended 
because it usually has a better adherence rate, has lower treatment 
costs, and also involves fewer risks of harmful drug effects than the 
combined use of several drugs [15]. A total of 32 (54.4%) respondents 
had health problems besides hypertension. Most of these other health 
problems were diabetes and hyperlipidemia. Both of these conditions 
increase the risk of complications of hypertension and organ damages 
in the heart, kidney, and brain [15].
Respondents’ knowledge and beliefs about drugs
The scores of respondents based on variables can be shown in Table 2.
Table 2 was shown that the respondents’ knowledge was quite high. The 
longer someone is having health problems; the information obtained 
regarding the issue tends to increase. Most respondents were able to 
recognize the antihypertensive drugs used and could refer exactly how 
many times a day and when the drug is used, but there were some of the 
respondents could not name the drug antihypertensive use. Such lack of 
knowledge is very risky since hypertensive patients should use the drug 
in the long term and are likely to have other health problems that have 
to be consulted to a different health service provider or perform self-
medication. The name of the drug is important to note so that they may 
mention again whenever a medical worker asks regarding the drugs 
routinely used. A large number of antihypertensive drugs alone or in 
various combinations are available, and physicians need to choose the 
most appropriate drug for a particular patient [16]. The medical worker 
can choose drugs that do not interact or commit a therapy duplication 
with the drug already administered [6].
The goal of the therapy of hypertension is to prevent deaths from 
the disease by inhibiting the progression of the disease with a target 
systolic blood pressure is <150 mmHg and diastolic blood pressure is 
<90 mmHg for the age of 60 years or more without diabetes and chronic 
kidney disease [15]. Some respondents (12 of 57) had false or lack of 
knowledge about those targets. The explanation on the matter is very 
important so that the respondent can recognize whether the therapeutic 
goal is reached or not during a routine inspection or self-blood pressure 
measurement at home. Achieving the goal of therapy will make the 
patient satisfied with the results of treatment, and it can provide a 
positive influence on the adherence of drug use [17]. A total of 10 out 
of 57 respondents considered that they only took antihypertensive 
medications when blood pressure rises or symptoms occur. It is very 
dangerous considering hypertension is often without symptoms, and 
the use of medication should be a routine to keep blood pressure 
stable as targeted. Efforts to prevent and treat hypertension through 
varieties of programs addressed to the associated problems should 
be continuously implemented including improvement of adherence to 
prescribed medications provided to an individual hypertensive patient 
and lifestyle modifications which in turn reduce its complications, 
morbidities, and mortalities [18]. The irregular use of drugs will lead 
to treatment failure and increase the likelihood of organ damage and 
complications due to hypertension [15].
Nearly half of the respondents (27 of 57) had a perception that the use 
of the drug once a day means the drug can be used at any time as long 
as it is only consumed once a day. The interval of drug use is associated 
with t1/2 of the drug so that the use drug with no fixed intervals can lead 
to the uncontrolled accumulation and fluctuation of drug levels in the 
blood so that they can increase the risk of toxic effects of the drug. In 
the elderly, the condition can be more dangerous with respect to drug 
pharmacodynamic changes due to aging, such as reduced body fluids 
and slowing of the rate of elimination [6].
On the measurement of perceived threat, most respondents felt that 
their hypertension could be severe and affect the future condition 
with respect to organ damage and costs to be incurred due to the 
nonadherent use of the drug. These results differ from other studies in 
which respondents felt that hypertension was an episodic, symptomatic 
disease, so antihypertensive medication was taken only when symptoms 
occur [19]. One’s perception of health problems suffered was greatly 
influenced by the local culture and beliefs of the people around him/
her [17]. This means that the truth of the information is very important 
to encourage the formation of positive attitudes toward the problem.
Most respondents were sure that by adherently using drugs they could 
control their hypertension, but there were some respondents who feel 
that they only required drugs when symptoms occur such as headache 
and stiff neck. The adherence with drug use was strongly influenced 
by previous experience in the use of drugs [17]. Someone who had 
tried not to be adherent and did not experience meaningful losses in 
the form of pain or discomfort was likely to repeat nonadherence. It is 
feasible to do under conditions where disease and therapeutic success 
is not significantly experienced by the patient, so efforts to maintain the 
consistency of adherence are very important. Objectives and results of 
therapy which are clearly communicated will bring satisfaction to the 
therapy and provide a good experience on adherence so that they can 
strengthen the establishment of an adherence of drug use [20].
On the measurement of perceived barrier, most respondents felt that 
barriers to medication adherence were quite low, especially those 
that were related to physical barriers. Most respondents felt able to 
set up and use their own medicines. Barriers to adherence that often 
experienced by respondents were the concerns about the effects of 
long-term drug use and drug dependence. In the process of developing 
a new drug, advanced age is not a criterion in clinical testing, so that 
information about the safety of drugs on the elderly is also limited [6]. 
Some experts agreed that drug response in elderly is different with 
younger groups as a result of changes in the body due to aging. These 
conditions put the elderly as a group vulnerable to the incidence of 
drug side effects. Some respondents said that the continuous use of 
drugs would damage the kidneys. Basically, there are no drugs that are 
pharmacologically effective without causing harm, so consideration of 
the use of drugs has always been based on the ratio of benefits against 
the risks that can be posed by the drug use. On this basis, the health 
worker should explain that the possibility of kidney damage caused 
by hypertension that is not controlled is greater than that from the 
harmful effects of antihypertensive drugs used [15].
The belief of respondents to be able to adhere to use the drug in this study 
was very high, especially in terms of understanding the instructions 
and uses it properly. However, more than half of respondents were 
difficult to remember the medication schedule. This is probably due to 
a decline in cognitive functions due to aging. A simpler management of 
the therapy with small types of drugs used will lead to adherence [15]. 
The communication and cooperation between the pharmacist and the 
doctor who treated the patient is very important to resolve the matter. 
Table 2: Scores of respondents based on variables








1 Knowledge 0-11 3-11 8.11±2.249
2 Perceived threat 5-25 11-25 19.35±3.056
3 Perceived benefit 5-25 15-25 19.58±2.195
4 Perceived barriers 6-36 6-23 15.02±3.204
5 Perceived self-efficacy 7-35 14-35 27.47±3.185
SD: Standard deviation
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Pharmacists can play a role as conduits of information to doctors 
regarding several drug options that can be tailored to a patient’s ability 
to adhere.
The adherence of drug use
Advanced age is a risk group for nonadherent use of the drug with 
respect to cognitive and motor abilities that began to decline. However, 
there were no studies that actually prove that the elderly are more 
nonadherent than the younger group. Elderly people usually adjust 
the schedule to take medication with daily activities, such as after 
breakfast, before going to bed every night, and so on, while the younger 
group is often overlooked because of the many activities taken during 
the duration of medication.
The results show that most respondents (73.3%) adhered to the drug 
use. Respondents were able to follow instructions since the treatment 
of hypertension is a long-term therapy, and respondents have used 
drugs for a long time so that taking the drug has become a daily routine. 
In addition, there was still a good deal of awareness among respondents 
that with age the health problems will increase and that the use of drugs 
is needed to maintain the quality of life. However, there were suspicions 
that some respondents were hiding the medicine (pill-dumping) to 
give the impression of adherence that the drug has been consumed in 
appropriate amounts (white coat adherence).
Nonadherence could occur because the respondents use the drug 
more than instructed (overuse) or less than instructed (underuse) and 
could be caused by external and internal factors of the respondents. 
An example of external factors of overuse in this study was in drug 
services in pharmacy, the pharmacist provides drug products with 
different strengths compared to the required dose, and the respondents 
(patients) did not read the instructions carefully. It is also caused 
when respondents maintain excessive (double) drug use because the 
remainder of the drug from a previous visit and the drug given to the 
next visit bear different trade names, making respondents use both 
drugs simultaneously. The internal factors of overuse were respondents 
had completely forgotten that they have already taken the drug, 
ensuring the repeated use of the same drug. Underuse in the group of 
respondents of this study can occur because the respondents actually 
forget to take the drug, feel bored, and feel that they are already healed, 
and fear unwanted effects on long-term drug use.
The downside of measuring adherence with the pill count method is 
that the determination of adherence and nonadherence is simply based 
on the number of drugs used, while the timing, frequency, and interval 
of usage cannot be measured. The difference in these three aspects can 
significantly affect the clinical outcome [15].
Relationships between variables
The result of data analysis of the relationships between variables 
shown in Table 3.
Table 3 shows that the respondents’ knowledge about drugs was related 
to the perception of the seriousness of the threat of disease progression 
if they were not adherent to drug use. Given that hypertension usually 
does not cause symptoms, the perceived threat was not pain that 
bothers a patient that encourages a person to take a drug.
Perceptions of threat development of the disease could be formed when 
patients are given education about hypertension, its risk factors, and 
potential complications that will occur due to the nonadherent use of 
the medicine, and they are explained that the purpose of the treatment 
of hypertension is not to cure the disease but to control blood pressure 
to prevent organ damage due to uncontrolled blood pressure [15].
Increasing knowledge can also lead to the increase of the belief of 
respondents on the benefits of adherence of the use of drugs as shown 
in Table 3. In some diseases that do not cause symptoms including 
hypertension, the benefits of medication cannot always be felt so that 
the wrong perception about the benefits of the drug can reduce the 
adherence of drug use. The role of pharmacists is essential to establish 
the motivation for elderly patients with hypertension to able to adhere 
to the therapy. The drug information is not merely about how to use 
the drug, but it should be more emphasized on the consequences of 
correct use to the development of the disease and the patients’ quality 
of life.
The knowledge of respondents about the drug was also associated 
with their own beliefs to be able to adhere to the therapy. The results 
show that the instructions on the use of drugs are quite clear and easy 
to understand so that respondents believed that they could adhere to 
the instruction, but the elderly tend to be forgetful and confused with 
complicated and varying schedules to taking drugs. Pharmacists can 
help to make it easier to remember to take medication by providing 
readable time table schedules with larger text size, or give a medicine 
box that comes with the days and times to take drugs. The use of this 
medicine box is not only help respondents remember when to take 
the drug so that they do not miss (underuse), but also can prevent the 
respondents from taking double doses of drugs, where the condition 
(overuse) can be more dangerous among the elderly in connection 
with a reduction in the proportion of bodily fluids and the slowing of 
elimination rate due to aging.
Based on the Spearman analysis of correlation of knowledge with 
adherence to drugs, there were no significant relationships as shown 
in Table 4.
Meanwhile, during the test of the relationship between the beliefs of 
respondents about drug use with the adherence to drug use, it was 
found that belief in the HBM variable that is related to adherence to 
drug use was only perceived barrier with a correlation coefficient of 
−0.290. The negative sign indicated that the association was inverse 
where higher perceived barrier means lower adherence. Atkinson said 
that the adherence established by patient preferences is the result of 
an analysis of the advantages and disadvantages of the intervention 
received, in this case, drug intervention [20]. Among this study’s 
respondents, it was apparently the perceived barriers that had more 
influence on the decision to use drugs, mainly those related to the fear 
of drugs’ side effects and the false perception regarding long-term drug 
use. Some studies also had similar results where the biggest obstacle for 
the elderly to adhere to therapy was the concern about side effects [21].
Eraker said that the patient’s knowledge about the disease and 
treatment would affect the decision of the patient, but might not 
necessarily affect adherence [17]. This was consistent with the findings 
that knowledge was related to some belief variables (perceived threat, 
perceived benefits, and perceived self-efficacy), but not associated 
with adherence. The above description was in line with Horne who 
divides nonadherence into two categories: Intentional nonadherence 
and unintentional nonadherence [22]. Deliberate nonadherence is 
Table 3: Pearson correlation test results
Pearson correlation Perceived threat Perceived benefit Perceived barriers Perceived self‑efficacy
significant r significant r significant r significant r
Knowledge 0.000 0.522 0.043 0.269 0.261 -0.151 0.015 0.319
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usually associated with a low belief in treatment that makes patients 
not motivated to use the drug, whereas unintentional nonadherence is 
the result of the inability of patients to use the drug, usually linked to 
a decline in cognition and dexterity. Among this study’s respondents, 
the majority of nonadherence cases in the use of drugs were caused 
accidentally. This was also evidenced by the results of research that 
adherence was related to the amount of drug used with a correlation 
coefficient of −0.302 in which the more drugs were used by patients; 
the less adherence tends to be. This result was also consistent with 
studies in other countries that the lack of adherence among the elderly 
was more often caused by accidents due to memory loss [23,24] and the 
complexity of the regimentation of doses [25].
The main priority for intervention to improve adherence of drug use in 
populations with similar characteristics with this study was to lower the 
perceived or experienced barriers by improving the populations’ ability 
to manage their own medicine. But considering that the capabilities are 
usually declining due to aging, the cooperation of the family or caregiver 
is indispensable for the success of the therapy. This statement does not 
mean that increased motivations by increasing the belief of patients 
are not required to improve adherence. Horne said that the quality 
of the relationship between health professionals and patients would 
increase the belief of patients to health professionals and interventions 
provided and ultimately would motivate patients to adhere [22]. The 
statement also applies to the elderly as proven by several studies [26]. 
Pharmacists as one of the most competent categories of health workers 
who understand the use of drugs has an obligation and a strategic 
position to promote the goals of therapy based on the pharmaceutical 
care [27,28].
The limitation of this study was the division of adherent, and 
nonadherent categories were based on the previous studies linking 
adherence with the medical consequences of drug use that occurs 
in adult subjects with hypertension [29]. The consequences may be 
different in elderly subjects. In addition, the respondent criterion of 
the study was elderly people who use antihypertensive drugs of all 
active ingredients, while each of the active ingredients has different 
characteristics and might influence the respondents’ experience of the 
benefits and side effects that can affect the respondent’s decision to 
adhere.
CONCLUSION
There was a relationship between the respondents’ knowledge about 
drugs with belief about the threat of the development of hypertension 
due to nonadherence when using drugs, belief about the benefits of 
adherence to drug use, and belief in respondents’ ability to adhere 
to use drugs, although that belief was not related to the adherence 
to drug use. Knowledge of the drug also did not directly relate to the 
adherence to drug use. Only beliefs about barriers to adherent drug 
use were associated with adherence to drug use with a negative 
correlation coefficient. There needs to be necessary measures to 
minimize the obstacles for elderly patients to adhere, especially 
those related to concerns over the long-term drug use by providing 
correct information about medicines and improving the quality of 
the relationship with health professionals, especially pharmacists. 
Barriers in patients associated with reduced physical and cognitive 
abilities also need attention. Collaboration among health professionals, 
especially physicians and pharmacists, are needed to be determining 
the regimentation that is most precise and simplest by considering the 
patient’s ability to adhere.
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